BOSTON, NEW YORK, MONTREAL, Dec. 8 /PRNewswire-FirstCall/ - ICBS Ltd. (OTCPK: ICBT), announced today that it has formed a new International company, with Chinese partners, Dr. Paul Yip and W.Woo of New Boston Holding Group Inc.
The new company Red Dragon Consulting & Investments, will now be squarely focused on quickly seizing the attractive opportunities this transaction has created to increase top-line growth as well as achieving significant contacts in the Pacific rim.
"With the joint venture now complete, ICBS is a stronger, more broadly based company than ever before, with increased capacity to reach new opportunities and the ability to provide expertise and analysis with enhanced expansion for products and services for both the North American and China markets. We are looking forward to the promise of this venture and to building value for our shareholders." said Garth McIntosh, chief executive officer of ICBS
The new company will be headquartered in Boston with offices in Montreal and Toronto.
"This represents a significant step for ICBS in our strategy to accelerate growth in our core business," said Garth McIntosh, chief executive officer of ICBS. "Today, we significantly increased the depth and breadth of our coverage in the Asian market and are working with individuals who know the marketplace , and who already have existing relationships. As a result , we also now have a greater presence in targeted international markets — including the Pacific rim countries — where we see significant opportunities for growth, as well as greater coverage in several key industries, including energy , pharmaceutical, environmental and transportation".
"This new partnership will be instrumental in the development of BioSpec products throughout Asia." said Don Saunders, President of BioSpec Global Solutions Inc.
New Boston Holding Group Inc., is an American company representing interests in China, with strong connections to the Chinese government.
ICBS specializes in mergers and acquisitions (M&A) advisory services and invests in selective businesses with potential for high growth.
BioSpec Global Solutions has developed state-of-the-art technologies for rapid, onsite (remote) monitoring of microbial contamination in drinking water, recreational water, agriculture & food production, pharmaceuticals and medical applications.
Legal Notice Regarding Forward-Looking Statements:
Safe Harbour: This press release contains forward-looking information within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbour created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of ICBS Limited, to be materially different from the statements made herein.
SOURCE Inter Canadian Business Service